ProShares Ultra Nasdaq Biotechnology (BIB)'s 30-day implied volatility (IV30) was 48.9% at the close on October 22, 2026, up from 47.3% the day before, against a 52-week range of 33.5% to 61.0%. Its 20-day historical volatility was 54.1%.
Data as of October 22, 2026.